Mixed Signals: Q1 2025 Recall Report Shows Dramatic Variations Across Industries

Policy changes create uncertainty as consumer products and pharmaceutical recalls climb while automotive sector finds relief, Sedgwick reports.
By: | May 21, 2025
green pill at conveyor belt in the pharmaceutical factory

While the total number of U.S. product recalls remained relatively stable at 775 in the first quarter of 2025, some sectors experienced significant increases in recall activity and others saw notable declines, creating a mixed picture of product safety trends nationwide, according to Sedgwick’s quarterly product recall analysis.

Consumer products faced a substantial rise in Q1 recall events, reaching levels not seen in over a decade, while pharmaceutical recalls continued an upward trajectory, the report detailed. Conversely, the automotive sector enjoyed a period of relative stability with fewer recalls.

In addition, Trump Administration policy changes have introduced new regulatory dynamics, creating both challenges and opportunities for manufacturers across all industries as they navigate shifting compliance requirements and enforcement priorities.

Recalls Reach Record Levels in Some Sectors

The first quarter of 2025 revealed divergent recall trends across industries, Sedgwick reported.

Consumer products experienced a 90.6% increase in recalls, with 101 events representing the highest quarterly total since Q1 2011. This marks only the eighth time since Q4 1997 that consumer product recalls have exceeded 100 in a quarter, though the total units affected actually decreased by 43.7% to 4.64 million, the report noted.

Pharmaceutical recalls increased 7.4% to 87 events, with units impacted climbing 42.3% to 27.74 million — the highest figure in two years and the third consecutive quarter of growth in recall activity for this sector.

Similarly, USDA food recalls rose 28.6% to nine events, though the volume dropped substantially by 96.5% to 425,317 pounds.

Other sectors, meanwhile, saw declines in recall events during the quarter, according to the report:

  • Automotive recalls fell 13.3% to 215 events, representing the second-lowest quarterly total in nearly five years. More significantly, the 3.73 million units affected marked the lowest quarterly total in over 12 years.
  • Medical device recalls decreased by 8.9% to 236 events, with units recalled dropping 42.1% to 18.58 million, the lowest quarterly total in three years.
  • FDA food recall events decreased 3.8% to 127, yet these experienced a dramatic increase in units affected — jumping 232.1% to reach a seven-quarter high.

Political Shifts Reshape Regulatory Landscape

The Trump Administration’s policy changes have created significant uncertainty across all industries, according to Sedgwick. Tariffs and trade issues dominated the quarter, particularly affecting the automotive sector, where U.S. manufacturers and dealers struggled with duties on imported steel, aluminum, vehicles, and parts, as well as retaliatory measures from other countries.

“There have been several stops and starts, which has disrupted planning efforts and created ongoing supply chain and pricing concerns,” the report noted regarding the automotive industry.

The administration has rescinded many Biden-era Executive Orders and targeted various policies of the previous administration, including automobile emissions and AI regulations. Federal agency staffing cuts and reduced funding for projects like pharmaceutical research are expected to slow regulatory approval processes and affect enforcement actions, the report stated.

In the food sector, the “Make America Healthy Again” initiative promises increased scrutiny of ingredients and updates to nutritional guidelines. The report indicated this sector may also face challenges from evolving tariffs, as much of the produce sold in U.S. markets is imported.

Despite the administration change, the Consumer Product Safety Commission (CPSC) is expected to maintain its focus on infant and children’s safety and unsafe products in online marketplaces, according to the report.

Industry-Specific Focus Areas Emerge

Each industry faces distinct challenges and regulatory focus areas in the changing environment, Sedgwick reported.

For medical devices, data integrity remains a priority. In March, the FDA published a notification warning about unreliable data from third-party testing facilities and announced it would make public any letters sent to labs whose data would no longer be accepted for marketing authorization submissions. This transparency will allow “study sponsors and device manufacturers to avoid disreputable facilities.”

The pharmaceutical industry is adapting to leadership changes under the new Secretary of Health and Human Services, Robert F. Kennedy Jr. Class I pharmaceutical recalls — the most serious category — increased to 14 in Q1 from six in Q4 2024, with affected units growing to 978,475 from 113,097.

In consumer products, enforcement actions have already intensified. The CPSC issued two fines totaling $28,275,000 in the first quarter of fiscal year 2025 — surpassing both the number and amount of penalties for all of FY 2024, the report noted.

The automotive sector saw electrical systems emerge as the leading cause of recalls (44 events), followed by equipment-related issues (33 recalls) and power train problems (16 events). The largest single automotive recall in the quarter involved 376,241 vehicles due to potential power loss in steering assist systems.

For food products, foreign materials and the combination of misbranding and undeclared allergens tied as the top reasons for USDA recalls with three events each. By product category, poultry led with four recalls and 342,605 pounds affected, while beef (63,440 pounds) and pork (18,120 pounds) followed.

Obtain the full report here. &

The R&I Editorial Team can be reached at [email protected].

More from Risk & Insurance